신경혈관 기기 시장 분석 및 예측(-2035년) : 유형별, 제품 유형별, 기술별, 용도별, 최종 사용자별, 재질별, 디바이스별, 프로세스별, 기능별

Neurovascular Devices Market is anticipated to expand from $5.17 billion in 2024 to $10.48 billion by 2034, growing at a CAGR of approximately 7.3%. The Neurovascular Devices Market encompasses medical tools designed to treat neurovascular disorders, such as aneurysms and strokes, involving the brain's blood vessels. This market includes stents, embolic coils, and thrombectomy devices, emphasizing minimally invasive techniques. Rising incidences of neurovascular diseases, coupled with technological advancements and an aging population, propel market growth. Innovation focuses on enhancing device efficacy and patient outcomes, fostering partnerships between healthcare providers and manufacturers to address evolving clinical needs.

The Neurovascular Devices Market is experiencing robust growth, propelled by advancements in medical technology and increasing prevalence of neurovascular disorders. The embolization devices segment is the top performer, driven by the rising adoption of minimally invasive procedures. Within this segment, coiling devices are particularly prominent due to their effectiveness in treating aneurysms. The second highest performing segment is the cerebral angioplasty and stenting systems, with balloon catheters gaining traction for their role in managing stenosis. The thrombectomy devices segment is also witnessing significant growth, underscored by the increasing incidence of ischemic strokes and the demand for rapid intervention solutions. In this sub-segment, aspiration catheters are emerging as a favored choice due to their efficiency in clot removal. Additionally, the neurothrombectomy devices are gaining popularity for their ability to restore blood flow swiftly. The market is poised for further expansion as technological innovations continue to enhance device efficacy and patient outcomes.

Market Snapshot:

The Neurovascular Devices Market is characterized by a dynamic landscape with a diverse array of product offerings. Market share is distributed among key players who are continually innovating with new product launches. Pricing strategies are competitive, reflecting the high demand for advanced neurovascular solutions. Companies are focusing on enhancing device efficacy and patient outcomes, driving growth through technological advancements. The market is buoyed by the increasing prevalence of neurovascular disorders and a growing emphasis on minimally invasive procedures. Competition within the neurovascular devices sector is intense, with leading firms vying for market dominance through strategic partnerships and acquisitions. Benchmarking reveals that innovation and regulatory adherence are critical for maintaining a competitive edge. Regulatory influences, particularly in North America and Europe, are shaping product development and market entry strategies. The Asia-Pacific region is emerging as a lucrative market, driven by increased healthcare investments. The market is poised for robust growth, propelled by technological advancements and a rising demand for effective neurovascular interventions.

Geographical Overview:

The neurovascular devices market is witnessing diverse growth trajectories across various regions. North America remains at the forefront, buoyed by advanced healthcare infrastructure and a high prevalence of neurovascular disorders. The region's commitment to technological innovation and substantial investments in research and development further propel market expansion. Europe follows closely, with a strong focus on enhancing healthcare systems and increasing awareness of neurovascular conditions. The Asia Pacific region is emerging as a significant growth pocket, driven by rapidly improving healthcare infrastructure and rising healthcare expenditure. Countries like China and India are at the helm, benefiting from large patient populations and increasing government initiatives to improve healthcare access. Latin America and the Middle East & Africa are also showing potential, with growing investments in healthcare and a rising demand for advanced medical devices. These regions are starting to recognize the importance of addressing neurovascular health, creating lucrative opportunities for market players.

Key Trends and Drivers:

The Neurovascular Devices Market is experiencing robust growth, propelled by the increasing prevalence of neurological disorders. An aging population worldwide is significantly driving demand, as age-related neurovascular conditions rise. Technological advancements, notably in minimally invasive procedures, are enhancing treatment efficacy and patient recovery times. The integration of artificial intelligence in diagnostic and therapeutic processes is another key trend, improving precision and outcomes in neurovascular interventions. Furthermore, expanding healthcare infrastructure in emerging economies is opening new avenues for market penetration. Regulatory approvals and favorable reimbursement policies are further catalyzing market expansion. Growing awareness and early diagnosis of neurovascular diseases are increasing the adoption of advanced medical devices. Additionally, strategic collaborations and acquisitions among key industry players are fostering innovation and market consolidation. These dynamics underscore a promising outlook for stakeholders in the neurovascular devices sector, with opportunities for substantial growth and innovation.

Restraints and Challenges:

The neurovascular devices market encounters several notable restraints and challenges. Foremost is the stringent regulatory environment, which imposes rigorous approval processes. This can delay the introduction of innovative devices and increase costs for manufacturers. Furthermore, the high cost of neurovascular devices presents a significant barrier, particularly in developing regions where healthcare budgets are constrained. The market also grapples with a shortage of skilled healthcare professionals trained in neurovascular interventions. This limits the adoption of advanced devices and procedures. Additionally, the complexity of neurovascular procedures necessitates specialized training, which can be both time-consuming and costly. Another challenge is the limited reimbursement landscape in certain regions. This can deter healthcare providers from investing in cutting-edge technologies. Finally, the rapid pace of technological advancements may render existing devices obsolete, compelling companies to continuously innovate, thereby increasing research and development expenses.

Key Players:

MicroVention, Penumbra, Stryker Neurovascular, Medtronic Neurovascular, Terumo, Johnson & Johnson Neurovascular, Balt International, Phenox, Acandis, InspireMD, Sequent Medical, Blockade Medical, Neuravi, Rapid Medical, NeuroVasc Technologies

Research Scope:

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Material Type
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Process
• 2.9 Key Market Highlights by Functionality

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Embolic Protection Devices
  • 4.1.2 Neurothrombectomy Devices
  • 4.1.3 Aneurysm Coiling & Embolization Devices
  • 4.1.4 Cerebral Balloon Angioplasty & Stenting Systems
  • 4.1.5 Support Devices
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Coils
  • 4.2.2 Stents
  • 4.2.3 Catheters
  • 4.2.4 Flow Diverters
  • 4.2.5 Guidewires
  • 4.2.6 Balloon Occlusion Devices
  • 4.2.7 Liquid Embolics
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Endovascular
  • 4.3.2 Surgical Clipping
  • 4.3.3 Flow Disruption
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Ischemic Stroke
  • 4.4.2 Cerebral Aneurysm
  • 4.4.3 Arteriovenous Malformations & Fistulas
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Hospitals
  • 4.5.2 Ambulatory Surgical Centers
  • 4.5.3 Specialty Clinics
• 4.6 Market Size & Forecast by Material Type (2020-2035)
  • 4.6.1 Platinum
  • 4.6.2 Nitinol
  • 4.6.3 Cobalt Chromium
  • 4.6.4 Stainless Steel
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Coiling Devices
  • 4.7.2 Clot Retrievers
  • 4.7.3 Balloon Occlusion Devices
• 4.8 Market Size & Forecast by Process (2020-2035)
  • 4.8.1 Coiling
  • 4.8.2 Stenting
  • 4.8.3 Thrombectomy
  • 4.8.4 Embolization
• 4.9 Market Size & Forecast by Functionality (2020-2035)
  • 4.9.1 Therapeutic
  • 4.9.2 Diagnostic

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 End User
    • 5.2.1.6 Material Type
    • 5.2.1.7 Device
    • 5.2.1.8 Process
    • 5.2.1.9 Functionality
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 End User
    • 5.2.2.6 Material Type
    • 5.2.2.7 Device
    • 5.2.2.8 Process
    • 5.2.2.9 Functionality
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 End User
    • 5.2.3.6 Material Type
    • 5.2.3.7 Device
    • 5.2.3.8 Process
    • 5.2.3.9 Functionality
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 End User
    • 5.3.1.6 Material Type
    • 5.3.1.7 Device
    • 5.3.1.8 Process
    • 5.3.1.9 Functionality
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 End User
    • 5.3.2.6 Material Type
    • 5.3.2.7 Device
    • 5.3.2.8 Process
    • 5.3.2.9 Functionality
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 End User
    • 5.3.3.6 Material Type
    • 5.3.3.7 Device
    • 5.3.3.8 Process
    • 5.3.3.9 Functionality
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 End User
    • 5.4.1.6 Material Type
    • 5.4.1.7 Device
    • 5.4.1.8 Process
    • 5.4.1.9 Functionality
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 End User
    • 5.4.2.6 Material Type
    • 5.4.2.7 Device
    • 5.4.2.8 Process
    • 5.4.2.9 Functionality
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 End User
    • 5.4.3.6 Material Type
    • 5.4.3.7 Device
    • 5.4.3.8 Process
    • 5.4.3.9 Functionality
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 End User
    • 5.4.4.6 Material Type
    • 5.4.4.7 Device
    • 5.4.4.8 Process
    • 5.4.4.9 Functionality
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 End User
    • 5.4.5.6 Material Type
    • 5.4.5.7 Device
    • 5.4.5.8 Process
    • 5.4.5.9 Functionality
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 End User
    • 5.4.6.6 Material Type
    • 5.4.6.7 Device
    • 5.4.6.8 Process
    • 5.4.6.9 Functionality
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 End User
    • 5.4.7.6 Material Type
    • 5.4.7.7 Device
    • 5.4.7.8 Process
    • 5.4.7.9 Functionality
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 End User
    • 5.5.1.6 Material Type
    • 5.5.1.7 Device
    • 5.5.1.8 Process
    • 5.5.1.9 Functionality
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 End User
    • 5.5.2.6 Material Type
    • 5.5.2.7 Device
    • 5.5.2.8 Process
    • 5.5.2.9 Functionality
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 End User
    • 5.5.3.6 Material Type
    • 5.5.3.7 Device
    • 5.5.3.8 Process
    • 5.5.3.9 Functionality
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 End User
    • 5.5.4.6 Material Type
    • 5.5.4.7 Device
    • 5.5.4.8 Process
    • 5.5.4.9 Functionality
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 End User
    • 5.5.5.6 Material Type
    • 5.5.5.7 Device
    • 5.5.5.8 Process
    • 5.5.5.9 Functionality
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 End User
    • 5.5.6.6 Material Type
    • 5.5.6.7 Device
    • 5.5.6.8 Process
    • 5.5.6.9 Functionality
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 End User
    • 5.6.1.6 Material Type
    • 5.6.1.7 Device
    • 5.6.1.8 Process
    • 5.6.1.9 Functionality
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 End User
    • 5.6.2.6 Material Type
    • 5.6.2.7 Device
    • 5.6.2.8 Process
    • 5.6.2.9 Functionality
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 End User
    • 5.6.3.6 Material Type
    • 5.6.3.7 Device
    • 5.6.3.8 Process
    • 5.6.3.9 Functionality
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 End User
    • 5.6.4.6 Material Type
    • 5.6.4.7 Device
    • 5.6.4.8 Process
    • 5.6.4.9 Functionality
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 End User
    • 5.6.5.6 Material Type
    • 5.6.5.7 Device
    • 5.6.5.8 Process
    • 5.6.5.9 Functionality

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 MicroVention
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Penumbra
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Stryker Neurovascular
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Medtronic Neurovascular
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Terumo
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Johnson & Johnson Neurovascular
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Balt International
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Phenox
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Acandis
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 InspireMD
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Sequent Medical
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Blockade Medical
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Neuravi
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Rapid Medical
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 NeuroVasc Technologies
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us